相关实验视频

Updated: Jan 17, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

卵巢癌治疗结果的比较回顾性分析:新辅助疗法与或没有手术干预

Ravi Iyengar¹, Gopireddy Murali Mohan Reddy², Parthiban Kumaresan³

¹M.CH Surgical Oncology, Associate Professor, Department of Surgery, Dhanalakshi Srinivan Medical College and Hospital, Allithurai Road Puthur Trichy, No3, 1St Street, Bharathi Nagar, Perambalur, Tamil Nadu 620017 India.

Indian journal of surgical oncology

|September 15, 2025

概括

与手术结合的新辅助化疗 (NACT) 显示,晚期卵巢癌患者的生存率有所改善. 与单独使用NACT相比,这种方法可能会提高结果,突出了定制治疗的好处.

科学领域:

在瘤学瘤学.
妇科瘤学妇科瘤学

背景情况:

卵巢癌是印度女性的主要死亡原因,通常在晚期被诊断出来.
研究最佳治疗策略,包括新辅助化疗 (NACT),对于改善患者的治疗结果至关重要.

研究的目的:

为了比较晚期卵巢癌患者的生存结果,仅用NACT治疗,而不是NACT随后进行手术.

主要方法:

84名晚期卵巢癌 (IIIC/IV阶段) 患者的回顾性分析.
卡普兰-梅尔生存分析和考克斯回归被用于统计评估.
收集的数据包括人口统计,瘤特征和并发症.

主要成果:

晚期卵巢癌与T3瘤和阳性瘤细胞学显著影响了复发风险.
平均总生存时间为9年,复发时间为8年.
与手术相结合的NACT显示了潜在的生存结果的改善.

结论:

将新辅助化疗与手术干预相结合,可能为晚期卵巢癌提供有益的结果.
量身定制的治疗方法,强调NACT,对于管理卵巢癌至关重要.
进一步研究NACT在晚期卵巢癌中的作用是有必要的.

关键词:

新辅助化学疗法新辅助化学疗法卵巢癌是发生在卵巢中的癌症.复发风险复发风险复发风险手术干预是一种手术干预.生存结果的结果.

更多相关视频

Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma

Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma

Published on: January 22, 2022

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...